Heading1

Heading2

Manuscripts

Fehrist Awzan Advia Mufrada (فہرست اوزان ادویہ مفردہ)

 Introductory

S.NO :4357 AMAR ID :AMAR/MS/4357
TITLE OF THE MANUSCRIPT :Fehrist Awzan Advia Mufrada (فہرست اوزان ادویہ مفردہ) SOURCE LOCATION :Ibn Sina Academy of Medieval Medicine and Sciences (IAMMS), Aligarh, UP, India
PLACE & STATE :Uttar Pradesh ACCESSION NO. AT SOURCE :
ACCESSION NO.AT NIIMH, HYDERBAD :904

 Technical

OTHER TITLE :INA/ AUTHOR NAME :Hakim Mohammed Abdul Hafiz (حکیم محمد عبدالحفیظ)/INA
CO-AUTHOR NAME :INA REDACTOR'S NAME :INA
COMMENTATOR NAME : NAME OF THE COMMENTARY :
LANGUAGE OF THE COMMENTATOR: AUTHOR DATE :INA
COMMENTATOR DATE : SCRIBE :
SCRIBE DATE AND PLACE : AYUSH SYSTEM :Unani
SUBJECT:Single drugs(Unani Pharmacology) LANGUAGE :Persian
SCRIPT :Persian

 Textual

AUTHOR'S BEGINNING SENTENCE (UNICODE)/(DIACRITICAL) :Ba fazlihi tala Fehrist Awzan Advia Mufrada Mustamala/
SCRIBE'S BEGINNING SENTENCE (UNICODE)/(DIACRITICAL) :/
AUTHOR'S ENDING SENTENCE (UNICODE)/(DIACRITICAL) :Sapistan, Arq-e-gulab, Unnab, Gul Gauzaban, Kasniz khushk,----Aabe lemu/
SCRIBES ENDING SENTENCE (UNICODE)/(DIACRITICAL) :/INA
COLOPHON (UNICODE)/(DIACRITICAL) :/ CHAPERTIZATION:Chapterised
EXTENT :Incomplete, Some folios are missing in the end
REMARKS :Red letters were not seen in the manuscript especially to highlight the chapters

 Physical

MATERIAL : SIZE :
No. of FOLIOS :16 No. of PAGES :32
No. of LINES PER FOLIOS : No. of LINES PER PAGE:14
No. of LETTERS PER LINE :13 GRANTHAMANA :
MISSING FOLIOS :Some folios are missing in the end ILLUSTRATIONS :
CONDITION :Good, Readable

 Catalogue

CATALOGUE STATUS : CATALOGUE MSS.NUMBER :
CATALOGUE TITLE :INA CATALOGUE PART :INA
CATALOGUE VOLUME :INA CATALOGUE EDITOR:INA
CATALOGUE PUBLISHER :INA CATALOGUE YEAR OF PUBLICATION :INA
CATALOGUE ADDITIONAL DETAILS :INA

 Publication Details

PUBLICATION STATUS :No data was found PUBLICATION LANGUAGE :INA
PUBLICATION AVAILABILITY :INA PUBLICATION EDITOR :INA
PUBLICATION TRANSLATOR :INA PUBLICATION PUBLISHER:INA
PUBLICATION YEAR:INA PUBLICATION PLACE :INA
ABOUT MANUSCRIPT :The Fehrist Awzan Advia Mufrada Manuscript is a detailed document that focuses on single (uncompounded) drugs, outlining their daily use for treating diseases affecting various bodily systems. Here are the key points elaborated: 1. Scope of the Manuscript: The manuscript serves as a comprehensive reference for practitioners and researchers in the field of medicine, particularly those interested in traditional or herbal remedies. It lists single drugs, meaning each entry describes a single, uncombined substance rather than a mixture or compound. 2. Diseases and Bodily Systems: The document categorizes drugs based on the diseases or bodily systems they target, such as the respiratory system, digestive system, nervous system, etc. This systematic approach allows for easy navigation and quick reference for specific ailments. 3. Dosages: One of the manuscript's key features is the detailed dosage information provided for each drug.Proper dosage is crucial in medical treatment to ensure efficacy while minimizing potential side effects or toxicity. Dosages may vary based on factors such as the patient's age, weight, severity of the disease, and overall health condition. 4. Historical and Cultural Context: The manuscript likely has roots in a specific traditional medical practice, possibly Unani, Ayurveda, or another herbal medicine system. Understanding the historical and cultural background of the manuscript can provide insights into its application and relevance in contemporary medicine. 5. Applications and Usage: The practical applications of the drugs listed are described, including how they are prepared, administered, and any special considerations or contraindications. This information is valuable for practitioners to ensure safe and effective treatment. 6. Scientific and Medical Value: Such manuscripts are valuable not only for their historical significance but also for the potential discovery of effective natural remedies. Modern researchers may study these manuscripts to identify bioactive compounds that can lead to the development of new drugs.

 Digitization Status

DIGITIZED BY :CCRAS-NIIMH DIGITIZATION DATE :March 2023